CAS: 33676-00-5; (7R,8R,9S)-9-(3,4-Dimethoxyphenyl)-4-Methoxy-7,8-Bis(Methoxymethyl)-6,7,8,9-Tetrahydrobenzo[g][1,3]Benzodioxole

上下游产品

(6aR,9aR,10S)-5-Bromo-10-(3,4-dimethoxy-phenyl)-4-methoxy-6a,7,9a,10-tetrahydro-6H-furo[3',4':6,7]naphtho[1,2-d][1,3]dioxol-9-one methyl iodide r-1-(3,4-dimethoxyphenyl)-t-2,c-3-bishydroxymethyl-6-methoxy-7,8-methylenedioxy-1,2,3,4-tetrahydronaphthalene9-(3,4-Dimethoxy-phenyl)-4-methoxy-8-methoxymethyl-naphtho[1,2-d][1,3]dioxole-7-carbaldehyde (8R,9S)-9-(3,4-Dimethoxy-phenyl)-4-methoxy-8-methoxymethyl-8,9-dihydro-naphtho[1,2-d][1,3]dioxole-7-carbaldehyde

专利信息

专利号:US-7829124-B2
优先权日:2001-04-26
标题:Use of Phyllanthus constituents for treating or preventing infections caused by hepatitis B-viruses
发明人：OTT MICHAEL; MANNS MICHAEL P
权利人:OTT MICHAEL; MANNS MICHAEL P
摘要:The disclosure relates to a method of inhibiting synthesis of viral DNA in a mammal infected with a hepatitis B virus. This method includes administering at least one Phyllanthus component or substance to a mammal infected with the hepatitis B virus. It also includes inhibiting hepatitis B viral DNA synthesis in the mammal using the Phyllanthus component or substance. The disclosure also relates to a method of inhibiting viral gene expression in a mammal infected with a hepatitis B virus. This method includes administering at least one Phyllanthus component or substance to a mammal infected with the hepatitis B virus. It also includes inhibiting expression of at least one hepatitis B viral gene in the mammal using the Phyllanthus component or substance. These methods may form part of a method of preventing or treating hepatitis B infection.